Wikipedia Linking - Buserelin
Google Scholar Search - Buserelin
Drug Information Portal (U.S. National Library of Medicine) - Buserelin
PubChem Compound Summary - Buserelin
Drug Bank - Buserelin
KEGG (Kyoto Encyclopedia of Genes and Genomes) - Buserelin
http://www.ebi.ac.uk/
- Buserelin
http://www.ncbi.nlm.nih.gov/ - Buserelin
http://toxnet.nlm.nih.gov/ Hazardous Substances Data Bank - Buserelin http://prostatecanceruk.org/ What is buserelin? Buserelin is a form of hormone therapy called an LHRH (luteinizing hormonereleasing hormone) agonist. It comes as an injection and as a nasal spray. The brand name is Suprefact®. Buserelin and other LHRH agonists work by stopping the brain from telling your body to make testosterone. Without testosterone the prostate cancer cells are not able to grow. Buserelin will not cure prostate cancer but it can keep the cancer under control for many months or years.
http://wildpro.twycrosszoo.org/ Buserelin
is a peptide hormone which is chemically analogous to
the releasing hormone (RH) of the luteinising hormone
(LH) and follicle stimulating hormone (FSH) thus a gonadotrophine
releasing hormone (GnRH) analogue. The mode of action
of Receptal corresponds to the physiologic-endocrinological
action of the naturally occurring gonadotrophin releasing
hormone: GnRH leaves the hypothalamus via the hypophyseal
portal vessels and enters the anterior lobe of the hypophysis.
Here it induces the secretion of the two gonadotrophins
FSH and LH into the peripheral blood stream. These then
act physiologically to cause maturation of ovarian follicles,
ovulation and luteinization in the ovary.
|